Beken
1 known investors
Beken Bio develops nanobiology technology combined with machine learning for early cancer detection by targeting abundant biomarkers. The company serves the medical field and cancer prevention sector.
Investors · 1
Competitors · 1
by search overlapCompanies competing with Beken for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Beken do?
- Beken Bio develops nanobiology technology combined with machine learning for early cancer detection by targeting abundant biomarkers. The company serves the medical field and cancer prevention sector.
- Who are Beken's investors?
- Beken's investors include Boot64 Ventures.